SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-009429
Filing Date
2017-05-08
Accepted
2017-05-08 16:44:39
Documents
3
Period of Report
2017-05-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insy-8k_20170502.htm 8-K 81474
2 EX-99.1 insy-ex991_6.htm EX-99.1 10540
3 GRAPHIC g2017050820285617351.jpg GRAPHIC 12929
  Complete submission text file 0001564590-17-009429.txt   111287
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 17823045
SIC: 2834 Pharmaceutical Preparations